MYLAN 6120 MYLAN 6120 Pill - pink capsule-shape, 17mm
Generic Name: diltiazem
Pill with imprint MYLAN 6120 MYLAN 6120 is Pink, Capsule-shape and has been identified as Diltiazem Hydrochloride Extended-Release (SR) 120 mg. It is supplied by Mylan Pharmaceuticals Inc.
Diltiazem Hydrochloride SR is used in the treatment of Heart Failure; Angina Pectoris Prophylaxis; High Blood Pressure and belongs to the drug classes calcium channel blocking agents, group IV antiarrhythmics. Risk cannot be ruled out during pregnancy. Diltiazem Hydrochloride SR 120 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for MYLAN 6120 MYLAN 6120





Diltiazem Hydrochloride Extended-Release (SR)
- Generic Name
- diltiazem
- Imprint
- MYLAN 6120 MYLAN 6120
- Strength
- 120 mg
- Color
- Pink
- Size
- 17.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Calcium channel blocking agents, Group IV antiarrhythmics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- Inactive Ingredients
-
diethyl phthalate,
gelatin,
hypromelloses,
maltodextrin,
methacrylic acid - methyl methacrylate copolymer (1:2),
polyethylene glycol,
povidone,
propylene glycol,
silicon dioxide,
sodium lauryl sulfate,
ferrosoferric oxide,
titanium dioxide,
FD&C Red No. 40,
FD&C Blue No. 2,
FD&C Blue No. 1,
D&C Yellow No. 10
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
00378-6120 | Mylan Pharmaceuticals Inc. |
51079-0926 | UDL Laboratories Inc. |
More about Diltiazem Hydrochloride SR (diltiazem)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: calcium channel blocking agents
- Breastfeeding
- En español
Patient resources
Other brands
Cardizem, Cartia XT, Dilt-XR, Cardizem CD, ... +7 more
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.